Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic-pharmacodynamic relationships.

about

Challenges for the in vivo quantification of brain neuropeptides using microdialysis sampling and LC-MS.

P2860

Q38935590-BA502493-E310-4723-8773-2F9C573B0FF2

P2860

Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic-pharmacodynamic relationships.

Item

http://www.wikidata.org/entity/Q41184173

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effects of sarizotan in animal ...... pharmacodynamic relationships.

@en

type

Item

label

Effects of sarizotan in animal ...... pharmacodynamic relationships.

@en

prefLabel

Effects of sarizotan in animal ...... pharmacodynamic relationships.

@en

P1476

Effects of sarizotan in animal ...... pharmacodynamic relationships.

@en

P2093

Andrew McCreary

http://www.w3.org/2001/XMLSchema#string

Ann-Kristin Jenssen

http://www.w3.org/2001/XMLSchema#string

Carsten Tober

http://www.w3.org/2001/XMLSchema#string

Christopher G Parsons

http://www.w3.org/2001/XMLSchema#string

Claudia C Jatzke

http://www.w3.org/2001/XMLSchema#string

Gunnar Flik

http://www.w3.org/2001/XMLSchema#string

Jean C Bizot

http://www.w3.org/2001/XMLSchema#string

Richard Kostrzewa

http://www.w3.org/2001/XMLSchema#string

Russell W Brown

http://www.w3.org/2001/XMLSchema#string

Sergio Greco

http://www.w3.org/2001/XMLSchema#string

P2860

The neuropharmacology of impulsive behaviour

Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology

Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride.

Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.

Role of medial prefrontal and orbitofrontal monoamine transporters and receptors in performance in an adjusting delay discounting procedure.

Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile.

Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia.

A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study.

D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.

Characterization of atypical antipsychotic drugs by a late decrease of striatal alpha1 spectral power in the electropharmacogram of freely moving rats

P2888

s00702-015-1392-6

P304

1221-1238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-015-1392-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273888971

http://www.w3.org/2001/XMLSchema#string

P6179

1035949857

http://www.w3.org/2001/XMLSchema#string

P698

25796190

http://www.w3.org/2001/XMLSchema#string

Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic-pharmacodynamic relationships.

about

P2860

P2860

Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic-pharmacodynamic relationships.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698